shopping cart Your cart is empty
  • Home
  • Healthcare
  • Healthcare Analytical Testing Services Market By Type (Bioanalytical Testing Services, Physical Characterization Services, Method...

Healthcare Analytical Testing Services Market By Type (Bioanalytical Testing Services, Physical Characterization Services, Method Validation, Raw Material, Batch Release Testing Services, Stability Testing, Microbial Testing), By End Users (Pharmaceutical And Biopharmaceutical Companies, Medical Devices Companies, Contract Research Organizations), By Sample (Raw Materials, Finished Products, In Process Samples, Environmental Samples) , Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jun 27, 2016

Key Findings


The global healthcare analytical testing services market is expected to grow at the CAGR of 12.1 % during 2016-2022 and is expected to reach $4710 million till 2022. Growth in market is mainly driven by the rising demand for analytical services for large-molecule drugs and biologics, increasing acceptance of the quality by design approach in pharmaceutical manufacturing and rising demand from the nutraceutical industry, increasing outsourcing of analytical testing by pharmaceutical companies. Apart from that, enhanced quality standards in the pharmaceutical industry, rapid growth in the biologic biosimilar market and presence of a large pool of analytical testing companies are further expected to boost the growth of global healthcare analytical testing services market. However, the shortage of skilled professionals and pricing pressure are being faced by market players in the healthcare analytical testing services industry thatact as a barrier in the growth of global healthcare analytical testing services market to a certain extent. Healthcare analytics has multitude of challenges and issues coming in the current scenario where pressures related to resource crunches, disease surveillance etc. Besides,regulations on healthcare providers & health insurance companies,consolidation of health records and operational advantages to the healthcare industry in terms of revenue management cycle, are the domains where healthcare analytics can be used widely. The technological and cultural barriers related to confidentiality of the information, data breach, data source pointor security issues, and lack of skilled personnel may hinder the growth of healthcare analytical testing services industry across the globe.


Market Segment Insight


Theglobal healthcare analytical testing services market is majorly segmented intotype, end users, sample and regional outlook.Onthe basis of type, market is divided into bio analytical testing services, physical characterization services, method validation, raw material testing, batch release testing services, stability testing, microbial testing and environmental testing. In type, bio analytics testing services is having the largest market share, in 2015. The share is majorly contributedbylarge number of biologic molecules in the pipeline because of growing bio pharmaceutical industries.In end users, market is divided into pharmaceutical and biopharmaceutical companies, medical devices companies and contract research organizations.The pharmaceutical and bio pharmaceutical companies are having the largest market share inglobal healthcare analytical testing services market of end users segment in 2015. The reason for major leadership of pharmaceutical and bio pharmaceutical companies is growing focus on delivering high quality products, rising demand for analytical testing by regulators and increased R&D expenditure to develop new drug molecules.In sample segment, market is divided into raw materials, finished products, in process sample and environmental sample. Raw materials in sample segment is having the largest market share in global healthcare analytical testing services market in 2015.In regional outlook market is divided into North America, Europe, Asia Pacific and Rest of the World. Asia pacific has been estimated to growwith remarkable CAGR in the forecasted period whereas North America leads this market.


Regional Insight


Theglobal healthcare analytical testing services market is divided into North America, Europe, Asia Pacific and Rest of the World.North America is having the largest market share in global healthcare analytical testing services marketowing to high quality standards in pharmaceutical industry, presence of large pool of analytical testing providers and rapid growth of bio similar and biologics market. Asia Pacific is fastest growing market of global healthcare analytical testing services. Huge R&D expenditure in drug development, innovation in life sciences due to governmental support, growing focus of pharmaceutical companies in the Asia Pacific region due to low manufacturing cost. India and China are the two major countries in Asia Pacific region. Europe is also showing remarkable growth in this market due to favorable government regulations, and rising healthcare industries. Rest of the world is showing low market growth in terms of revenue owing to lack of skilled expertise in this region.


Competitive Insights


Some of the keymarket players are Intertek Group Plc., Eurofins Scientific SE, Charles River Laboratories International Inc., Bioreliance Corporation, WUXI Pharmatech Inc., Source bioscience, SGS, Pace Analytical services Inc., NSF Health science, Medistri Sa, etc.Acquisitions, new product development, collaborations, joint ventures, mergers and expansions are the key strategies adopted by the market players to sustain in the market

CHAP 1. METHODOLOGY & SCOPE 16
1.1. RESEARCH METHODOLOGY 16
1.2. RESEARCH SCOPE & ASSUMPTIONS 16
1.3. LIST OF DATA SOURCES 16


CHAP 2. EXECUTIVE SUMMARY 17
2.1. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SUMMARY & KEY BUYING CRITERIA 17
2.2. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET OUTLOOK 17
2.3. MARKET SEGMENTATION ANALYSIS 17
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 17
2.5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET VALUE CHAIN ANALYSIS 17
2.6. VENDOR LANDSCAPE 17


CHAP 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 18
3.1. MARKET DRIVER ANALYSIS 18
3.1.1. RISING DEMAND FROM THE NUTRACEUTICAL INDUSTRY 18
3.1.2. INCREASING OUTSOURCING OF ANALYTICAL TESTING BY PHARMACEUTICAL COMPANIES 18
3.1.3. GROWING DEMAND FOR ANALYTICAL SERVICES FOR BIOLOGICS AND LARGE MOLECULE DRUGS 18
3.2. MARKET RESTRAINT ANALYSIS 18
3.2.1. PRICING PRESSURE FACED BY MAJOR PLAYERS 18
3.2.2. SHORTAGE OF SKILLED PROFESSIONALS 18
3.3. KEY OPPORTUNITIES 18
3.3.1. RISING DEMAND FOR SPECIALIZED ANALYTICAL TESTING SERVICES 18
3.4. CHALLENGES 18
3.4.1. DEVELOPMENT OF APPROPRIATE DISSOLUTION METHODS 18
3.4.2. INNOVATIVE FORMILATION AND MEDICAL DEVICES DEMANDING A UNIQUE ANALUTICAL TESTING APPROACH 18


CHAP 4. INDUSTRY ANALYSIS 19
4.1. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET– PORTER’S FIVE FORCE MODEL 19
4.2. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET– PESTEL ANALYSIS 19
4.3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET– GAP ANALYSIS 19


CHAP 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY TYPE 2012-2022 ($ MILLION) 20
5.1. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY BIOANALYTICAL TESTING SERVICES 2012-2022 ($ MILLION) 21
5.2. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY PHYSICAL CHARACTERIZATION SERVICES 2012-2022 ($ MILLION) 21
5.3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY METHOD VALIDATION 2012-2022 ($ MILLION) 21
5.4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY RAW MATERIAL TESTING 2012-2022 ($ MILLION) 22
5.5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY BATCH RELEASE TESTING SERVICES 2012-2022 ($ MILLION) 23
5.6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY STABILITY TESTING 2012-2022 ($ MILLION) 23
5.7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY MICROBIAL TESTING 2012-2022 ($ MILLION) 24
5.8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY ENVIRONMENTAL MONITORING 2012-2022 ($ MILLION) 24


CHAP 6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY END USERS 2012-2022 ($ MILLION) 25
6.1. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 2012-2022 ($ MILLION) 25
6.2. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY MEDICAL DEVICES COMPANIES 2012-2022 ($ MILLION) 25
6.3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY CONTRACT RESEARCH ORGANIZATIONS 2012-2022 ($ MILLION) 25


CHAP 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY SAMPLE 2012-2022 ($ MILLION) 26
7.1. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY RAW MATERIALS 2012-2022 ($ MILLION) 26
7.2. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY FINISHED PRODUCTS 2012-2022 ($ MILLION) 26
7.3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY IN PROCESS SAMPLES 2012-2022 ($ MILLION) 26
7.4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY ENVIRONMENTAL SAMPLES 2012-2022 ($ MILLION) 26


CHAP 8. GLOBAL ABLATION TECHNOLOGIES MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 27
8.1. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY REGION 2012-2022 ($ MILLION) 27
8.2. NORTH AMERICA 27
8.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
8.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
8.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 27
8.2.3.1. U.S. 27
8.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
8.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
8.2.3.2. CANADA 27
8.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
8.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
8.2.3.3. MEXICO 27
8.2.3.3.1. MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
8.2.3.3.2. MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
8.3. EUROPE 28
8.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
8.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
8.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 28
8.3.3.1. GERMANY 28
8.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
8.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
8.3.3.2. UK 28
8.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
8.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
8.3.3.3. FRANCE 28
8.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
8.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
8.3.3.4. SPAIN 28
8.3.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
8.3.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
8.3.3.5. REST OF EUROPE 28
8.3.3.5.1. REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 29
8.3.3.5.2. REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 29
8.4. ASIA PACIFIC 29
8.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
8.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
8.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 29
8.4.3.1. CHINA 29
8.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
8.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
8.4.3.2. INDIA 29
8.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
8.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
8.4.3.3. JAPAN 29
8.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
8.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 29
8.4.3.4. SOUTH KOREA 29
8.4.3.4.1. SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
8.4.3.4.2. SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 29
8.4.3.5. REST OF APAC 30
8.4.3.5.1. REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
8.4.3.5.2. REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
8.5. REST OF THE WORLD 30
8.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
8.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
8.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 30
8.5.3.1. LATIN AMERICA 30
8.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
8.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
8.5.3.2. MIDDLE EAST AND AFRICA 30
8.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
8.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30


CHAP 9. COMPETITIVE LANDSCAPE 31
9.1. ANABIOTEC 32
9.1.2. SCOT ANALYSIS 32
9.1.3. PRODUCT BENCHMARKING 32
9.1.4. STRATEGIC INITIATIVES 32
9.2. BAYER HEALTHCARE 32
9.2.2. SCOT ANALYSIS 32
9.2.3. PRODUCT BENCHMARKING 32
9.2.4. STRATEGIC INITIATIVES 32
9.3. BIORELIANCE CORPORATION (MERCK KGAA) 32
9.3.2. SCOT ANALYSIS 32
9.3.3. PRODUCT BENCHMARKING 32
9.3.4. STRATEGIC INITIATIVES 32
9.4. CHARLES RIVER LABORATORIES INTERNATIONAL INC. 32
9.4.2. PRODUCT BENCHMARKING 32
9.4.3. STRATEGIC INITIATIVES 32
9.5. ENVIGO 32
9.5.2. SCOT ANALYSIS 32
9.5.3. PRODUCT BENCHMARKING 32
9.5.4. STRATEGIC INITIATIVES 32
9.6. EUROFINS SCIENTIFIC SE 32
9.6.2. SCOT ANALYSIS 32
9.6.3. PRODUCT BENCHMARKING 33
9.6.4. STRATEGIC INITIATIVES 33
9.7. EXOVA GROUP PLC 33
9.7.2. SCOT ANALYSIS 33
9.7.3. PRODUCT BENCHMARKING 33
9.7.4. STRATEGIC INITIATIVES 33
9.8. INTERTEK GROUP PLC. 33
9.8.2. SCOT ANALYSIS 33
9.8.3. PRODUCT BENCHMARKING 33
9.8.4. STRATEGIC INITIATIVES 33
9.9. MEDISTRI SA 33
9.9.2. SCOT ANALYSIS 33
9.9.3. PRODUCT BENCHMARKING 33
9.9.4. STRATEGIC INITIATIVES 33
9.10. NSF HEALTH SCIENCE 33
9.10.2. SCOT ANALYSIS 33
9.10.3. PRODUCT BENCHMARKING 33
9.10.4. STRATEGIC INITIATIVES 33
9.11. PACE ANALYTICAL SERVICES INC. 33
9.11.2. SCOT ANALYSIS 33
9.11.3. PRODUCT BENCHMARKING 33
9.11.4. STRATEGIC INITIATIVES 33
9.12. PPD INC. 34
9.12.2. SCOT ANALYSIS 34
9.12.3. PRODUCT BENCHMARKING 34
9.12.4. STRATEGIC INITIATIVES 34
9.13. SGS 34
9.13.2. SCOT ANALYSIS 34
9.13.3. PRODUCT BENCHMARKING 34
9.13.4. STRATEGIC INITIATIVES 34
9.14. SOURCE BIOSCIENCE 34
9.14.2. SCOT ANALYSIS 34
9.14.3. PRODUCT BENCHMARKING 34
9.14.4. STRATEGIC INITIATIVES 34
9.15. WUXI PHARMATECH (CAYMAN) INC. 34
9.15.2. SCOT ANALYSIS 34
9.15.3. PRODUCT BENCHMARKING 34
9.15.4. STRATEGIC INITIATIVES 34

TABLE 1 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY TYPE 2012-2022 ($ MILLION) 34
TABLE 2 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY BIOANALYTICAL TESTING SERVICES 2012-2022 ($ MILLION) 34
TABLE 3 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY CELL BASED ASSAYS 2012-2022 ($ MILLION) 34
TABLE 4 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY VIROLOGY TESTING 2012-2022 ($ MILLION) 35
TABLE 5 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION 2012-2022 ($ MILLION) 35
TABLE 6 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY IMMUNOGENECITY AND NEUTRALIZING ANTIBODY TESTING 2012-2022 ($ MILLION) 35
TABLE 7 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY BIOMARKER TESTING 2012-2022 ($ MILLION) 35
TABLE 8 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY PHARMACOKINETIC TESTING 2012-2022 ($ MILLION) 35
TABLE 9 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY PHYSICAL CHARACTERIZATION SERVICES 2012-2022 ($ MILLION) 35
TABLE 10 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY LASER PARTICLE SIZE ANALYSIS 2012-2022 ($ MILLION) 35
TABLE 11 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY THERMAL ANALYSIS 2012-2022 ($ MILLION) 35
TABLE 12 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY IMAGE ANALYSIS 2012-2022 ($ MILLION) 35
TABLE 13 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY SURFACE AREA ANALYSIS 2012-2022 ($ MILLION) 35
TABLE 14 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY METHOD VALIDATION 2012-2022 ($ MILLION) 35
TABLE 15 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY EXTRACTABLES & LEACHABLES METHOD DEVELOPMENT AND VALIDATION2012-2022 ($ MILLION) 35
TABLE 16 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY PROCESS IMPURITY METHOD DEVELOPMENT AND VALIDATION 2012-2022 ($ MILLION) 35
TABLE 17 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY CLEANING VALIDATION METHOD DEVELOPMENT 2012-2022 ($ MILLION) 35
TABLE 18 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY ANALYTICAL STANDARD CHARACTERIZATION 2012-2022 ($ MILLION) 35
TABLE 19 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY PEAK IDENTIFICATION 2012-2022 ($ MILLION) 36
TABLE 20 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY TECHNICAL CONSULTING 2012-2022 ($ MILLION) 36
TABLE 21 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY OTHER METHOD VALIDATION SERVICES 2012-2022 ($ MILLION) 36
TABLE 22 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY RAW MATERIAL TESTING 2012-2022 ($ MILLION) 36
TABLE 23 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY COMPLETE COMPENDIAL TESTING 2012-2022 ($ MILLION) 36
TABLE 24 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY HEAVY METAL TESTING 2012-2022 ($ MILLION) 36
TABLE 25 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY CONTAINER TESTING 2012-2022 ($ MILLION) 36
TABLE 26 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY KARL FISCHER ANALYSIS 2012-2022 ($ MILLION) 36
TABLE 27 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY WET CHEMISTRY ANALYSIS 2012-2022 ($ MILLION) 36
TABLE 28 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY OTHER RAW MATERIAL TESTING SERVICES 2012-2022 ($ MILLION) 36
TABLE 29 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY BATCH RELEASE TESTING SERVICES 2012-2022 ($ MILLION) 36
TABLE 30 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY DISSOLUTION TESTING 2012-2022 ($ MILLION) 36
TABLE 31 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY PHYSICAL TESTS 2012-2022 ($ MILLION) 36
TABLE 32 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY ELEMENTAL IMPURITY TESTING 2012-2022 ($ MILLION) 36
TABLE 33 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY DISINTEGRATION TESTING 2012-2022 ($ MILLION) 36
TABLE 34 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY HARDNESS TESTING 2012-2022 ($ MILLION) 36
TABLE 35 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY FRIABILITY TESTING 2012-2022 ($ MILLION) 36
TABLE 36 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY STABILITY TESTING 2012-2022 ($ MILLION) 37
TABLE 37 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY DRUG SUBSTANCE STABILITY TESTING 2012-2022 ($ MILLION) 37
TABLE 38 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY FORMULATION EVALUATION STABILITY TESTING 2012-2022 ($ MILLION) 37
TABLE 39 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY STABILITY INDICATING METHOD VALIDATION 2012-2022 ($ MILLION) 37
TABLE 40 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY ACCELERATED STABILITY TESTING 2012-2022 ($ MILLION) 37
TABLE 41 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY PHOTOSTABILITY TESTING 2012-2022 ($ MILLION) 37
TABLE 42 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY OTHER STABILITY TESTING SERVICES 2012-2022 ($ MILLION) 37
TABLE 43 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY MICROBIAL TESTING 2012-2022 ($ MILLION) 37
TABLE 44 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY MICROBIAL LIMIT TESTING 2012-2022 ($ MILLION) 37
TABLE 45 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY STERILITY TESTING 2012-2022 ($ MILLION) 37
TABLE 46 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY ENDOTOXIN TESTING 2012-2022 ($ MILLION) 37
TABLE 47 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY PRESERVATIVE EFFICACY TESTING 2012-2022 ($ MILLION) 37
TABLE 48 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY WATER TESTING 2012-2022 ($ MILLION) 37
TABLE 49 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY OTHER MICROBIAL TESTING SERVICES 2012-2022 ($ MILLION) 37
TABLE 50 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY ENVIRONMENTAL MONITORING 2012-2022 ($ MILLION) 37
TABLE 51 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY AIR TESTING 2012-2022 ($ MILLION) 37
TABLE 52 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY WASTEWATER/ETP TESTING 2012-2022 ($ MILLION) 37
TABLE 53 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY OTHER ENVIRONMENTAL MONITORING SERVICES 2012-2022 ($ MILLION) 38
TABLE 54 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY END USERS 2012-2022 ($ MILLION) 38
TABLE 55 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 2012-2022 ($ MILLION) 38
TABLE 56 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY MEDICAL DEVICES COMPANIES 2012-2022 ($ MILLION) 38
TABLE 57 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY CONTRACT RESEARCH ORGANIZATIONS 2012-2022 ($ MILLION) 38
TABLE 58 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY SAMPLE 2012-2022 ($ MILLION) 38
TABLE 59 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY RAW MATERIALS 2012-2022 ($ MILLION) 38
TABLE 60 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY FINISHED PRODUCTS 2012-2022 ($ MILLION) 38
TABLE 61 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY IN PROCESS SAMPLES 2012-2022 ($ MILLION) 38
TABLE 62 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY ENVIRONMENTAL SAMPLES 2012-2022 ($ MILLION) 38
TABLE 63 GLOBAL ABLATION TECHNOLOGIES MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 38
TABLE 64 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET BY REGION 2012-2022 ($ MILLION) 38
TABLE 65 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
TABLE 66 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 38
TABLE 67 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 38
TABLE 68 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
TABLE 69 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 39
TABLE 70 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 39
TABLE 71 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 39
TABLE 72 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 39
TABLE 73 MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 39
TABLE 74 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 39
TABLE 75 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 39
TABLE 76 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 39
TABLE 77 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 39
TABLE 78 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 39
TABLE 79 39
TABLE 80 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 39
TABLE 81 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 39
TABLE 82 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 39
TABLE 83 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 39
TABLE 84 SPAIN 39
TABLE 85 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 39
TABLE 86 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 39
TABLE 87 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 40
TABLE 88 REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 40
TABLE 89 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 40
TABLE 90 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 40
TABLE 91 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 40
TABLE 92 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 40
TABLE 93 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 40
TABLE 94 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 40
TABLE 95 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 40
TABLE 96 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 40
TABLE 97 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 40
TABLE 98 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 40
TABLE 99 SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 40
TABLE 100 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 40
TABLE 101 REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 40
TABLE 102 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 40
TABLE 103 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 40
TABLE 104 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 41
TABLE 105 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 41
TABLE 106 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 41
TABLE 107 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 41
TABLE 108 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 41

FIGURE 1 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 41
FIGURE 2 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 41
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 41
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 41
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 41
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 41
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 41
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 41
FIGURE 9 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 41
FIGURE 10 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 41
FIGURE 11 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 42
FIGURE 12 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 42
FIGURE 13 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 42
FIGURE 14 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 42
FIGURE 15 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 42
FIGURE 16 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 42
FIGURE 17 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 42
FIGURE 18 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 42
FIGURE 19 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 42

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)